New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 29, 2013
20:01 EDTVNDAVanda says FDA grants priority review for tasimelteon NDA
Vanda Pharmaceuticals announced that the U.S. FDA has accepted the filing and granted a priority review classification to Vanda's New Drug Application for tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder in the totally blind. The FDA determined the action target date under Prescription Drug User Fee Act, to be January 31, 2014. The FDA has also tentatively scheduled an advisory committee meeting to discuss the tasimelteon application on November 14.
News For VNDA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 6, 2015
16:40 EDTVNDAVanda files $150M mixed securities shelf
July 2, 2015
09:07 EDTVNDAVanda has new Hetlioz patent listed in FDA Orange Book
Vanda announced that a Hetlioz patent is now listed in the FDA publication Approved Drug Products With Therapeutic Equivalence Evaluations, commonly known as the Orange Book. The 'patent was issued by the USPTO on June 23rd and expires in January 2033.
07:27 EDTVNDAPublic Citizen calls on FDA to correct labeling of Vanda's Hetlioz drug
Subscribe for More Information
June 24, 2015
10:03 EDTVNDAHigh option volume stocks: VNDA SN ADHD UNIS
June 23, 2015
19:03 EDTVNDAOn The Fly: After Hours Movers
UP AFTER PROVIDING GUIDANCE: MeetMe (MEET), up 18.8%. ALSO HIGHER: Nektar Therapeutics (NKTR), up 4.3% after being added to S&P 600... Quidel (QDEL), up 5% after receiving FDA clearance for new Solana molecular system and assay... Vanda Pharmaceuticals (VNDA), up 4.6% after announcing positive results from REPRIEVE study... Netflix (NFLX), up 3.4% after announcing seven-for-one stock split. LOWER: Alcobra (ADHD), down 2.5% after announcing that it will host a conference call and simultaneous webcast presentation to present results from the Phase II clinical trial of MDX... Sysco (SYY), down 2.6% after bid for U.S. foods blocked was blocked by a federal judge... Boeing (BA), down marginally after announcing CEO transition.
16:32 EDTVNDAVanda announces positive results from REPRIEVE study
Subscribe for More Information
07:36 EDTVNDAJMP Securities to hold a conference
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use